All

What are you looking for?

All
Projects
Results
Organizations

Quick search

  • Projects supported by TA ČR
  • Excellent projects
  • Projects with the highest public support
  • Current projects

Smart search

  • That is how I find a specific +word
  • That is how I leave the -word out of the results
  • “That is how I can find the whole phrase”

Circulating tumor cell-derived preclinical models: current status and future perspectives

The result's identifiers

  • Result code in IS VaVaI

    <a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F68081707%3A_____%2F23%3A00574949" target="_blank" >RIV/68081707:_____/23:00574949 - isvavai.cz</a>

  • Alternative codes found

    RIV/00216224:14310/23:00132481 RIV/61989592:15110/23:73623474 RIV/00098892:_____/23:10157953 RIV/00159816:_____/23:00079743 RIV/00209805:_____/23:00079360

  • Result on the web

    <a href="https://www.nature.com/articles/s41419-023-06059-6" target="_blank" >https://www.nature.com/articles/s41419-023-06059-6</a>

  • DOI - Digital Object Identifier

    <a href="http://dx.doi.org/10.1038/s41419-023-06059-6" target="_blank" >10.1038/s41419-023-06059-6</a>

Alternative languages

  • Result language

    angličtina

  • Original language name

    Circulating tumor cell-derived preclinical models: current status and future perspectives

  • Original language description

    Despite the advancements made in the diagnosis and treatment of cancer, the stages associated with metastasis remain largely incurable and represent the primary cause of cancer-related deaths. The dissemination of cancer is facilitated by circulating tumor cells (CTCs), which originate from the primary tumor or metastatic sites and enter the bloodstream, subsequently spreading to distant parts of the body. CTCs have garnered significant attention in research due to their accessibility in peripheral blood, despite their low abundance. They are being extensively studied to gain a deeper understanding of the mechanisms underlying cancer dissemination and to identify effective therapeutic strategies for advanced stages of the disease. Therefore, substantial efforts have been directed towards establishing and characterizing relevant experimental models derived from CTCs, aiming to provide relevant tools for research. In this review, we provide an overview of recent progress in the establishment of preclinical CTC-derived models, such as CTC-derived xenografts (CDX) and cell cultures, which show promise for the study of CTCs. We discuss the advantages and limitations of these models and conclude by summarizing the potential future use of CTCs and CTC-derived models in cancer treatment decisions and their utility as precision medicine tools.

  • Czech name

  • Czech description

Classification

  • Type

    J<sub>imp</sub> - Article in a specialist periodical, which is included in the Web of Science database

  • CEP classification

  • OECD FORD branch

    10601 - Cell biology

Result continuities

  • Project

    Result was created during the realization of more than one project. More information in the Projects tab.

  • Continuities

    P - Projekt vyzkumu a vyvoje financovany z verejnych zdroju (s odkazem do CEP)

Others

  • Publication year

    2023

  • Confidentiality

    S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Data specific for result type

  • Name of the periodical

    Cell Death & Disease

  • ISSN

    2041-4889

  • e-ISSN

    2041-4889

  • Volume of the periodical

    14

  • Issue of the periodical within the volume

    8

  • Country of publishing house

    DE - GERMANY

  • Number of pages

    12

  • Pages from-to

    530

  • UT code for WoS article

    001050089600001

  • EID of the result in the Scopus database

    2-s2.0-85168257527